# Royalty Pharma plc – aktieanalysens källarkiv Company page: https://spela.port0.org/company/royalty-pharma-plc Company JSON: https://spela.port0.org/company/royalty-pharma-plc/company.json Documents JSON: https://spela.port0.org/company/royalty-pharma-plc/documents.json Updated: 2026-08-06T04:56:15Z ## Market data - Nasdaq kurshistorik CSV: https://spela.port0.org/company/royalty-pharma-plc/market/history.csv - Nasdaq kurshistorik JSON: https://spela.port0.org/company/royalty-pharma-plc/market/history.json - Nasdaq manifest JSON: https://spela.port0.org/company/royalty-pharma-plc/market/manifest.json - SEC Company Facts JSON: https://spela.port0.org/company/royalty-pharma-plc/market/sec-companyfacts.json - SEC filing-manifest JSON: https://spela.port0.org/company/royalty-pharma-plc/market/sec-manifest.json - SEC sammanfattning JSON: https://spela.port0.org/company/royalty-pharma-plc/market/sec-summary.json ## Full-text source documents - SEC EDGAR | 8-K – 2026-08-05 – rprx-20260805.htm: https://spela.port0.org/company/royalty-pharma-plc/documents/sec-edgar-8-k-2026-08-05-rprx-20260805-htm/fulltext.txt - SEC EDGAR | 10-Q – 2026-08-05 – rprx-20260630.htm: https://spela.port0.org/company/royalty-pharma-plc/documents/sec-edgar-10-q-2026-08-05-rprx-20260630-htm/fulltext.txt - HTML part 1: https://spela.port0.org/company/royalty-pharma-plc/documents/sec-edgar-10-q-2026-08-05-rprx-20260630-htm/part-001.html - HTML part 2: https://spela.port0.org/company/royalty-pharma-plc/documents/sec-edgar-10-q-2026-08-05-rprx-20260630-htm/part-002.html - HTML part 3: https://spela.port0.org/company/royalty-pharma-plc/documents/sec-edgar-10-q-2026-08-05-rprx-20260630-htm/part-003.html - SEC EDGAR | 8-K – 2026-06-04 – d855771d8k.htm: https://spela.port0.org/company/royalty-pharma-plc/documents/sec-edgar-8-k-2026-06-04-d855771d8k-htm/fulltext.txt - SEC EDGAR | 8-K – 2026-05-28 – d131735d8k.htm: https://spela.port0.org/company/royalty-pharma-plc/documents/sec-edgar-8-k-2026-05-28-d131735d8k-htm/fulltext.txt - SEC EDGAR | 8-K – 2026-05-06 – rprx-20260506.htm: https://spela.port0.org/company/royalty-pharma-plc/documents/sec-edgar-8-k-2026-05-06-rprx-20260506-htm/fulltext.txt - SEC EDGAR | 10-Q – 2026-05-06 – rprx-20260331.htm: https://spela.port0.org/company/royalty-pharma-plc/documents/sec-edgar-10-q-2026-05-06-rprx-20260331-htm/fulltext.txt - HTML part 1: https://spela.port0.org/company/royalty-pharma-plc/documents/sec-edgar-10-q-2026-05-06-rprx-20260331-htm/part-001.html - HTML part 2: https://spela.port0.org/company/royalty-pharma-plc/documents/sec-edgar-10-q-2026-05-06-rprx-20260331-htm/part-002.html - SEC EDGAR | 8-K – 2026-04-13 – d871473d8k.htm: https://spela.port0.org/company/royalty-pharma-plc/documents/sec-edgar-8-k-2026-04-13-d871473d8k-htm/fulltext.txt - SEC EDGAR | 8-K – 2026-02-11 – rprx-20260211.htm: https://spela.port0.org/company/royalty-pharma-plc/documents/sec-edgar-8-k-2026-02-11-rprx-20260211-htm/fulltext.txt - SEC EDGAR | 10-K – 2026-02-11 – rprx-20251231.htm: https://spela.port0.org/company/royalty-pharma-plc/documents/sec-edgar-10-k-2026-02-11-rprx-20251231-htm/fulltext.txt - HTML part 1: https://spela.port0.org/company/royalty-pharma-plc/documents/sec-edgar-10-k-2026-02-11-rprx-20251231-htm/part-001.html - HTML part 2: https://spela.port0.org/company/royalty-pharma-plc/documents/sec-edgar-10-k-2026-02-11-rprx-20251231-htm/part-002.html - HTML part 3: https://spela.port0.org/company/royalty-pharma-plc/documents/sec-edgar-10-k-2026-02-11-rprx-20251231-htm/part-003.html - SEC EDGAR | 8-K – 2025-12-22 – d938129d8k.htm: https://spela.port0.org/company/royalty-pharma-plc/documents/sec-edgar-8-k-2025-12-22-d938129d8k-htm/fulltext.txt - SEC EDGAR | 8-K – 2025-12-22 – d35067d8k.htm: https://spela.port0.org/company/royalty-pharma-plc/documents/sec-edgar-8-k-2025-12-22-d35067d8k-htm/fulltext.txt - SEC EDGAR | 8-K – 2025-11-05 – rprx-20251105.htm: https://spela.port0.org/company/royalty-pharma-plc/documents/sec-edgar-8-k-2025-11-05-rprx-20251105-htm/fulltext.txt - SEC EDGAR | 10-Q – 2025-11-05 – rprx-20250930.htm: https://spela.port0.org/company/royalty-pharma-plc/documents/sec-edgar-10-q-2025-11-05-rprx-20250930-htm/fulltext.txt - HTML part 1: https://spela.port0.org/company/royalty-pharma-plc/documents/sec-edgar-10-q-2025-11-05-rprx-20250930-htm/part-001.html - HTML part 2: https://spela.port0.org/company/royalty-pharma-plc/documents/sec-edgar-10-q-2025-11-05-rprx-20250930-htm/part-002.html - HTML part 3: https://spela.port0.org/company/royalty-pharma-plc/documents/sec-edgar-10-q-2025-11-05-rprx-20250930-htm/part-003.html - SEC EDGAR | 8-K – 2025-09-16 – d58607d8k.htm: https://spela.port0.org/company/royalty-pharma-plc/documents/sec-edgar-8-k-2025-09-16-d58607d8k-htm/fulltext.txt - SEC EDGAR | 8-K – 2025-08-13 – d930454d8k.htm: https://spela.port0.org/company/royalty-pharma-plc/documents/sec-edgar-8-k-2025-08-13-d930454d8k-htm/fulltext.txt - SEC EDGAR | 8-K – 2025-08-06 – d90343d8k.htm: https://spela.port0.org/company/royalty-pharma-plc/documents/sec-edgar-8-k-2025-08-06-d90343d8k-htm/fulltext.txt - SEC EDGAR | 10-Q – 2025-08-06 – rprx-20250630.htm: https://spela.port0.org/company/royalty-pharma-plc/documents/sec-edgar-10-q-2025-08-06-rprx-20250630-htm/fulltext.txt - HTML part 1: https://spela.port0.org/company/royalty-pharma-plc/documents/sec-edgar-10-q-2025-08-06-rprx-20250630-htm/part-001.html - HTML part 2: https://spela.port0.org/company/royalty-pharma-plc/documents/sec-edgar-10-q-2025-08-06-rprx-20250630-htm/part-002.html - HTML part 3: https://spela.port0.org/company/royalty-pharma-plc/documents/sec-edgar-10-q-2025-08-06-rprx-20250630-htm/part-003.html